These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19295940)

  • 21. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
    AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study.
    Okunade KS; Badmos KB; Soibi-Harry AP; Garba SR; Ohazurike EO; Ozonu O; Akanmu AS; Ogunsola FT; Abdulkareem FB; Anorlu RI
    Acta Cytol; 2023; 67(3):248-256. PubMed ID: 36516788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical Cytology and Herpes Simplex Virus Type-2 Serology Among Human Immune Deficiency Virus Infected Women on Highly Active Antiretroviral Therapy in Enugu, Nigeria.
    Osinachi Ogu C; Uwadiegwu Achukwu P; Onubiwe Nkwo P; Ifeoma-Ossy Ogu R; Steven Onwukwe O; Chinonye Azubuike N; Obianuju Onyemelukwe A; Maryjoy Ifeorah I; Uzoamaka MC
    Curr HIV Res; 2022; 20(6):463-471. PubMed ID: 36380408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical Cancer Screening in a Human Immunodeficiency Virus Treatment Centre in Zaria North-Western Nigeria.
    Yahya A; Mustapha A; Kolawole AOD; Oguntayo AO; Lawal BK
    West Afr J Med; 2022 Mar; 39(3):291-298. PubMed ID: 35380751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
    Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
    AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sociodemographic and gynaecological factors that influence uptake of cervical cancer screening. A cross-sectional study in Calabar, Nigeria.
    Ago BU; Efiok EE; Abeng SE
    Afr Health Sci; 2022 Dec; 22(4):96-103. PubMed ID: 37092061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution.
    Gharoro EP; Ikeanyi EN
    Int J Gynecol Cancer; 2006; 16(3):1063-8. PubMed ID: 16803486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge, attitude, willingness of HIV counseling and testing and factors associated with it, among long distant drivers in Enugu, Nigeria: an opportunity in reduction of HIV prevalence.
    Ijeoma A; Ejikeme A; Theodora O; Chika O
    Afr Health Sci; 2018 Dec; 18(4):1088-1097. PubMed ID: 30766575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of utilization of papanicolaou smear among outpatient clinic attendees in north-eastern Nigeria.
    Bukar M; Takai IU; Audu BM
    Afr J Med Med Sci; 2012 Jun; 41(2):183-9. PubMed ID: 23185917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
    Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
    S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer awareness and cervical screening uptake at the Mater Misericordiae Hospital, Afikpo, Southeast Nigeria.
    Eze JN; Umeora OU; Obuna JA; Egwuatu VE; Ejikeme BN
    Ann Afr Med; 2012; 11(4):238-43. PubMed ID: 23103924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women.
    Ezechi OC; Gab-Okafor CV; Ostergren PO; Odberg Pettersson K
    BMC Public Health; 2013 Jan; 13():46. PubMed ID: 23327453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
    Assefa AA; Astawesegn FH; Eshetu B
    BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria.
    Ugwu EO; Obi SN; Ezechukwu PC; Okafor II; Ugwu AO
    Niger J Clin Pract; 2013; 16(2):249-52. PubMed ID: 23563471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical cancer risk factors among HIV-infected Nigerian women.
    Ononogbu U; Almujtaba M; Modibbo F; Lawal I; Offiong R; Olaniyan O; Dakum P; Spiegelman D; Blattner W; Adebamowo C
    BMC Public Health; 2013 Jun; 13():582. PubMed ID: 23767681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge attitudes and practices of cervical cancer screening among urban and rural Nigerian women: a call for education and mass screening.
    Nwankwo KC; Aniebue UU; Aguwa EN; Anarado AN; Agunwah E
    Eur J Cancer Care (Engl); 2011 May; 20(3):362-7. PubMed ID: 20345451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.